Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith M Martin

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
JAMA|July 25, 2023
Identifying Children Likely to Benefit From Antibiotics for Acute Sinusitis: A Randomized Clinical TrialNader Shaikh, Alejandro Hoberman, Timothy R Shope, et al.
Clinical and Vaccine Immunology : CVI|August 26, 2016
Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza VaccinationMin Z Levine, Judith M Martin, F Liaini Gross, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United StatesMichael Green, Coburn Allen, John Bradley, et al.
Pediatric Nephrology (Berlin, Germany)|November 24, 2019
Biomarkers that differentiate false positive urinalyses from true urinary tract infectionNader Shaikh, Judith M Martin, Alejandro Hoberman, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2006
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USAMichael D Green, Bernard Beall, Mario J Marcon, et al.
The Pediatric Infectious Disease Journal|May 25, 2012
Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of ageMark M Blatter, Nicola P Klein, Julie S Shepard, et al.
Vaccine|December 25, 2021
A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adultsKatherine V Williams, Bo Zhai, John F Alcorn, et al.
Journal of the Pediatric Infectious Diseases Society|May 26, 2023
A Randomized Controlled Trial to Compare Immunogenicity to Cell-Based Versus Live-Attenuated Influenza Vaccines in ChildrenKatherine V Williams, Zhu-Nan Li, Bo Zhai, et al.
Human Vaccines & Immunotherapeutics|April 17, 2020
Differential gene expression in peripheral blood mononuclear cells from children immunized with inactivated influenza vaccineJohn F Alcorn, Raghunandan Avula, Anish B Chakka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2026
Overview of 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adultsMiriam B Barshak, Jeffrey A Linder, Michael E Watson, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
JAMA|July 25, 2023
Identifying Children Likely to Benefit From Antibiotics for Acute Sinusitis: A Randomized Clinical TrialNader Shaikh, Alejandro Hoberman, Timothy R Shope, et al.
Clinical and Vaccine Immunology : CVI|August 26, 2016
Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza VaccinationMin Z Levine, Judith M Martin, F Liaini Gross, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United StatesMichael Green, Coburn Allen, John Bradley, et al.
Pediatric Nephrology (Berlin, Germany)|November 24, 2019
Biomarkers that differentiate false positive urinalyses from true urinary tract infectionNader Shaikh, Judith M Martin, Alejandro Hoberman, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2006
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USAMichael D Green, Bernard Beall, Mario J Marcon, et al.
The Pediatric Infectious Disease Journal|May 25, 2012
Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of ageMark M Blatter, Nicola P Klein, Julie S Shepard, et al.
Vaccine|December 25, 2021
A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adultsKatherine V Williams, Bo Zhai, John F Alcorn, et al.
Journal of the Pediatric Infectious Diseases Society|May 26, 2023
A Randomized Controlled Trial to Compare Immunogenicity to Cell-Based Versus Live-Attenuated Influenza Vaccines in ChildrenKatherine V Williams, Zhu-Nan Li, Bo Zhai, et al.
Human Vaccines & Immunotherapeutics|April 17, 2020
Differential gene expression in peripheral blood mononuclear cells from children immunized with inactivated influenza vaccineJohn F Alcorn, Raghunandan Avula, Anish B Chakka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2026
Overview of 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adultsMiriam B Barshak, Jeffrey A Linder, Michael E Watson, et al.
Pageof 10